EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Protective Effects of Guava Pulp on Cholestatic Liver Injury

Jian Peng, Chunyan Yue, Kai Qiu, Jie Chen, Maria-Angeles Aller, Kwang Suk Ko, Heping Yang iD

ISRN Hepatology · 2013

DOI: 10.1155/2013/601071 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ISRN Hepatology, 2013. Verfasst von Jian Peng und 6 weiteren Autor:innen. Beteiligte Einrichtung: National Hepatobiliary and Enteric Surgery Research Center, Xiangya Hospital of Central South University, 87 Xiangya Road, Changsha, Hunan 410008, Ch…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: NIDDK NIH HHS, National Natural Science Foundation of China, National Research Foundation of Korea.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cholestatic liver injury is a leading cause of chronic liver diseases involved with oxidative stress changes and inflammation; thus, antioxidant and anti-inflammation compound-rich guava may play a pivotal role in protecting against the cholestatic liver damages. Our aims for this study are to determine whether guava pulp (GP) has protective effects on cholestatic liver injury-induced mouse model and on interleukin-6 (IL-6) mediated proliferation of QBC939 cholangiocarcinoma cell line.

Methods

Mice were induced to cholestatic liver damage by left and median bile duct ligation (LMBDL) surgery and then treated with GP. Plasma and liver samples were collected for biochemical and pathological assays. 5-Bromo-2′-deoxyuridine (BrdU) assay and Western blots were used to detect proliferation and gene expression in QBC939 cells, respectively.

Results

Compared with LMBDL only group, in GP-treated mice, the levels of alanine aminotransferase (ALT) and bilirubin decreased, biliary epithelial cell proliferation and liver fibrogenesis were suppressed, Src/MEK/ERK1/2/c-Myc pathway and expressions of transforming growth factor β 1(TGF- β 1), tissue inhibitor of metalloproteinases TIMP), and procollagen 1 α 1(COL1 α 1) were downregulated significantly. Moreover, the GP extract reduced IL-6-enhanced QBC939 cell proliferation, p-ERK, and c-Myc expression as well.

Conclusions

GP may provide a new perspective for the treatment of cholestatic liver injury.

Autor:innen und Institutionen

  • National Hepatobiliary and Enteric Surgery Research Center, Xiangya Hospital of Central South University, 87 Xiangya Road, Changsha, Hunan 410008, China.
  • Surgery Department, School of Medicine, Complutense University, Madrid, Spain.
  • Department of Nutritional Science and Food Management, The College of Health Science, Ewha Womans University, Seoul, Republic of Korea.
  • Division of Gastroenterology and Liver Diseases, USC Research Center for Liver Diseases, Department of Medicine, Keck School of Medicine, USC, HMR Building, 415, 2011 Zonal Avenue, Los Angeles, CA 90033, USA.

ORCID-Profile: Heping Yang

Förderung

  • NIDDK NIH HHS
  • National Natural Science Foundation of China
  • National Research Foundation of Korea
  • University of Southern California

Zitieren

APA

Peng, J., Yue, C., Qiu, K., Chen, J., Aller, M. A., Ko, K. S., & Yang, H. (2013). Protective Effects of Guava Pulp on Cholestatic Liver Injury. ISRN Hepatology. https://doi.org/10.1155/2013/601071

Vancouver

Peng J, Yue C, Qiu K, Chen J, Aller MA, Ko KS, et al. Protective Effects of Guava Pulp on Cholestatic Liver Injury. ISRN Hepatology. 2013. doi:10.1155/2013/601071

BibTeX
@article{Peng2013,
  author = {Peng, Jian and Yue, Chunyan and Qiu, Kai and Chen, Jie and Aller, Maria-Angeles and Ko, Kwang Suk and Yang, Heping},
  title = {Protective Effects of Guava Pulp on Cholestatic Liver Injury},
  journal = {ISRN Hepatology},
  year = {2013},
  doi = {10.1155/2013/601071}
}
Kostenlos starten →